Media inquiries: (804) 924-5679

U.VA. TO HOST BAYER SYMPOSIUM ON INFECTIOUS DISEASES

Infectious diseases are the paramount threat to health, and their control the greatest promise of medical research in the 21st century. New challenges to the care of patients with infections present daily with emerging infectious diseases and resistance of old infectious diseases to current therapies.

Many of the national leaders in infectious diseases will be discussing clinical trends and promising research at the Bayer Symposium on Infectious Diseases, sponsored by the University of Virginia Division of Infectious Diseases. The conference, which is being held in honor of Dr. Gerald Mandell, head of the U.Va. infectious diseases division, will be held on Wednesday, May 3, in the Jordan Hall Conference Center Auditorium.

Reporters are invited to attend all or part of the conference. The schedule of presentations is:

8:00 a.m. Introduction: Dr. Robert M. Carey, dean, U.Va. School of Medicine Dr. Michael O. Thorner, chairman, U.Va. Department of Internal Medicine
8:30 a.m. Dr. James M. Hughes, chief, National Center for Infectious Diseases, Centers for Disease Control
Preventing emerging infectious diseases as we enter the 21st century - CDC's strategy.

9:00 a.m. Dr. R. Gordon Douglas, Jr., consultant, vaccines, infectious diseases, and global health, National Institute of Allergy and Infectious Diseases, NIH, and adjunct professor of medicine, Cornell University College of Medicine
Can public health and science work together? A vaccine story.

9:30 a.m. Dr. John E. Bennett, head, Clinical Mycology Section, National Institute of Allergy and Infectious Diseases
NIH bench science training for infectious diseases fellows: The NIH experience.

10:30 a.m. Dr. Stanley Falkow, professor, Department of Microbiology and Immunology, Stanford University Microbes as tools for cell biology
The microbe's view of infection.

11:00 a.m. Dr. P. Frederick Sparling, chairman, Department of Medicine, University of North Carolina, Chapel Hill
Iron piracy: Acquisition of transferrin-bound iron by bacterial pathogens.

1:00 p.m. Dr. Richard P. Wenzel, chairman, Department of Internal Medicine, Medical College of Virginia
New insights into sepsis and nosocomial bloodstream infection.

1:30 p.m. Dr. John I. Gallin, director, Clinical Center, National Institutes of Health
Pathogenesis and treatment of chronic granulomatous disease.

2:00 p.m. Dr. Merle A. Sande, chairman, Department of Internal Medicine, University of Utah
Pathophysiology of bacterial meningitis: Contribution of an animal model.

2:30 p.m. Dr. Anthony S. Fauci, director, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Host factors in the pathogenesis of HIV disease.

May 1, 2000